Spitz MR - Search Results

1

A risk model for prediction of lung cancer.

Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ. Spitz MR, et al. J Natl Cancer Inst. 2007 May 2;99(9):715-26. doi: 10.1093/jnci/djk153. J Natl Cancer Inst. 2007. PMID: 17470739

2

Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies.

Schantz SP, Spitz MR, Hsu TC. Schantz SP, et al. Among authors: spitz mr. J Natl Cancer Inst. 1990 Nov 21;82(22):1773-5. doi: 10.1093/jnci/82.22.1773. J Natl Cancer Inst. 1990. PMID: 1700135 Clinical Trial.

3

Cancer and age.

Newell GR, Spitz MR, Sider JG. Newell GR, et al. Among authors: spitz mr. Semin Oncol. 1989 Feb;16(1):3-9. Semin Oncol. 1989. PMID: 2645647 Review.

4

Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung.

Licciardello JT, Spitz MR, Hong WK. Licciardello JT, et al. Among authors: spitz mr. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):467-76. doi: 10.1016/0360-3016(89)90096-5. Int J Radiat Oncol Biol Phys. 1989. PMID: 2674075 Review.

5

Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis.

Spitz MR, Fueger JJ, Goepfert H, Hong WK, Newell GR. Spitz MR, et al. Cancer. 1988 Jan 1;61(1):203-8. doi: 10.1002/1097-0142(19880101)61:1<203::aid-cncr2820610134>3.0.co;2-6. Cancer. 1988. PMID: 3334949

6

In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients.

Trizna Z, Schantz SP, Lee JJ, Spitz MR, Goepfert H, Hsu TC, Hong WK. Trizna Z, et al. Among authors: spitz mr. Cancer Detect Prev. 1993;17(6):575-83. Cancer Detect Prev. 1993. PMID: 7506126

7

A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.

Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. Wu X, et al. Among authors: spitz mr. Cancer Res. 1995 Feb 1;55(3):557-61. Cancer Res. 1995. PMID: 7530597

8

Mutagen sensitivity as a biological marker of lung cancer risk in African Americans.

Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Spitz MR, et al. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):99-103. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7537995

9

Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.

Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR. Jin X, et al. Among authors: spitz mr. Carcinogenesis. 1995 Sep;16(9):2205-8. doi: 10.1093/carcin/16.9.2205. Carcinogenesis. 1995. PMID: 7554076

10

Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.

Lippman SM, Spitz MR, Huber MH, Hong WK. Lippman SM, et al. Among authors: spitz mr. Curr Opin Oncol. 1995 May;7(3):234-41. doi: 10.1097/00001622-199505000-00008. Curr Opin Oncol. 1995. PMID: 7654825 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters